Inspire vs UPPP for
Sleep Apnea

Two Surgical Paths for Obstructive Sleep Apnea

For adults with obstructive sleep apnea (OSA) who cannot tolerate CPAP, Capital ENT offers a continuum of options — from oral appliances to Inspire upper-airway stimulation to airway surgery including UPPP. The right choice is made through a thorough evaluation that often includes drug-induced sleep endoscopy (DISE), which lets our physicians directly observe how and where your airway collapses during sleep. No single approach is right for everyone, and our board-certified ENT specialists are experienced in all of them.

When evaluating outcomes for surgical sleep apnea treatment, the field uses the Sher criteria as the standard definition of surgical success: a postoperative AHI below 20 events per hour and a reduction of at least 50% from baseline. This definition, endorsed by the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), applies consistently to both Inspire and UPPP results described on this page. The FDA has approved Inspire for adults with moderate-to-severe OSA who have not tolerated CPAP and meet specific candidacy criteria; UPPP is a well-established surgical procedure for select patients with palatal-level obstruction.

Inspire Upper-Airway Stimulation

The long-term effectiveness of Inspire is documented by the STAR trial: at five years, patients had a median AHI reduction from 29.3 to 9.0 events per hour, demonstrating that results are durable over time (Woodson et al., Otolaryngology–Head and Neck Surgery, 2018).

Current FDA labeling approves Inspire for adults with an AHI of 15–65 events per hour and a BMI up to 40. Efficacy data are strongest at BMI ≤32; response may decrease at higher BMI, and Medicare coverage requires BMI ≤35. A Drug-Induced Sleep Endoscopy (DISE) is required before implantation: a finding of complete concentric collapse (CCC) at the palate excludes Inspire candidacy because the nerve stimulation cannot reliably open that collapse pattern.

Because Inspire is a neurostimulator implanted under the skin of the upper chest, it removes no palate or throat tissue. The device can be explanted if needed, but removal is itself a surgical reoperation — it is not trivial (documented in FDA MAUDE adverse-event reviews). Most patients find the implant to be low-burden: it is activated with a small remote at bedtime and requires no mask or machine.

UPPP (Uvulopalatopharyngoplasty)

UPPP removes or repositions the soft palate, uvula, and sometimes tonsillar tissue to enlarge the retropalatal airway. In a randomized controlled trial, mean AHI fell from 53.3 to 21.1 events per hour — note that this cohort had higher baseline severity, so these figures are not a direct head-to-head comparison with the Inspire STAR-trial numbers above.

UPPP is a reasonable option for select patients with palatal-level anatomy and can even be staged with or combined with Inspire in some cases (Steffen et al., Laryngoscope, 2019). Tissue removal is permanent, and recovery typically involves significant throat soreness for approximately two weeks.

A multicenter analysis using the ADHERE registry compared upper-airway stimulation to traditional airway surgery (including UPPP) across a large patient population. Postoperative AHI was approximately 10 events per hour for upper-airway stimulation versus 15 for surgery, with a higher rate of Sher-defined surgical success (postoperative AHI <20 AND ≥50% reduction from baseline) for stimulation (Huntley et al., Annals of Otology, Rhinology & Laryngology, 2021).

Capital ENT’s sleep program offers the full OSA treatment continuum — from oral appliances and CPAP optimization to Inspire implantation and airway surgery including UPPP. Rather than defaulting to a single approach, our board-certified ENT specialists use DISE-guided evaluation to match each patient to the option best suited to their specific airway anatomy, AHI, BMI, and preferences.

For patients who have tried CPAP without success, an evaluation with our sleep team is the right starting point. We review your sleep study results, medical history, and airway anatomy together, then recommend the treatment most likely to produce a lasting result. If your anatomy supports Inspire, we can walk you through candidacy criteria in detail. If palate-level surgery is more appropriate, UPPP — sometimes combined or staged with Inspire — is a well-established option our team performs.

• Full OSA treatment continuum — oral appliance, CPAP optimization, Inspire, airway surgery
• DISE-guided evaluation to identify where and how your airway collapses
• Board-certified ENT specialists experienced in both Inspire and airway surgery
• Insurance verification and prior authorization support for qualifying patients
• Four Central Texas locations — Austin, Lakeway, Marble Falls, and Dripping Springs